Caption Management’s ResMed RMD Stock Holding History

Caption Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$624K	Buy	+3,200	New	+$663K	﹤0.01%	1268
2025 Q2	–	Sell	-4,000	Closed	-$895K	–	1824
2025 Q1	$895K	Buy	+4,000	New	+$934K	0.01%	957
2022 Q2	–	Sell	-8,000	Closed	-$1.94M	–	1767
2022 Q1	$1.94M	Buy	+8,000	New	+$1.94M	0.02%	769
2020 Q4	–	Sell	-2,500	Closed	-$428K	–	1210
2020 Q3	$428K	Buy	+2,500	New	+$462K	0.01%	804

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Caption Management's RMD Position: Q2 2026 in Review

Caption Management opened a new position in ResMed (RMD) in Q2 2026: 3,200 shares worth $624K. The stake represents ﹤0.01% of the portfolio and ranks #1268 among its holdings. This is a return to the name: Caption Management previously reported a position in RMD as recently as Q1 2025.

Caption Management first reported a position in RMD in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.94M in Q1 2022. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Caption Management held 3,200 shares of ResMed worth $624K as of Q2 2026.
ResMed was a new Caption Management position in Q2 2026.
ResMed made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1268 holding.
Caption Management first reported a position in ResMed in Q3 2020 and has held it in 4 quarters since.
Caption Management's ResMed position peaked at $1.94M in Q1 2022.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.